The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of disorders affecting the testes, pituitary and hypothalamus, it has not been approved for treating age-related decrease in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study included approximately 800 older men with low testosterone and symptoms associated with this ailment, including http://tinyurl.com/jdmk5rh
sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men's heart health was carefully monitored.
Research has shown that testosterone deficiency is associated with several important health issues for example metabolic
syndrome, obesity, diabetes, and bone fractures Men who meet medical standards for treatment should receive therapy. Actually, your testosterone levels have likely been slowly decreasing for quite some time, a decline that usually starts around age 30.
And many girls have a knee jerk feeling that any hormone treatment can increase their risk of breast cancer. However, clinical studies demonstrate that testosterone not only doesn't increase a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser believes this will likely stay the status quo for a while, given the prohibitive cost of running the long-term safety studies needed to acquire more total FDA approval.